Apollon Wealth Management’s Nutex Health NUTX Stock Holding History

Apollon Wealth Management’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-102	Closed	-$49K	–	839
2022 Q2	$49K	Buy	+102	New	+$120K	﹤0.01%	725

Other funds holding NUTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EWP

Engrave Wealth Partners The Woodlands, Texas $350M AUM 13.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Apollon Wealth Management's NUTX Position: Q3 2022 in Review

Apollon Wealth Management sold out of Nutex Health (NUTX) in Q3 2022, closing a stake of 102 shares — an estimated $49K sold.

Apollon Wealth Management first reported a position in NUTX in Q2 2022 and held it in 1 quarter. The position peaked at $49K in Q2 2022. 51 funds tracked by Wall St. Rank hold NUTX as of Q3 2022.

Apollon Wealth Management reported no remaining Nutex Health position as of Q3 2022 after selling out during the quarter.
Apollon Wealth Management sold 102 Nutex Health shares in Q3 2022, an estimated $49K.
Apollon Wealth Management first reported a position in Nutex Health in Q2 2022 and held it in 1 quarter.
Apollon Wealth Management's Nutex Health position peaked at $49K in Q2 2022.
51 funds tracked by Wall St. Rank held Nutex Health as of Q3 2022.

Based on Apollon Wealth Management's 13F filing for Q3 2022, filed 8 Nov 2022.